Cardiology
New global heart failure definition exposes a policy gap: systems still diagnose too late and treat too narrowly
Global cardiovascular societies have released the Second Universal Definition of Heart Failure, shifting the field away from rigid ejection fraction thresholds and toward earlier detection, disease trajectory, underlying causes and global equity. The science is moving from “heart failure as a fixed diagnosis” to “heart failure as a dynamic, preventable and heterogeneous condition.”
Heart pumps save lives. FDA’s latest Impella alerts show why cardiac device safety cannot stop at approval.
Gene therapy is entering cardiology. Friedreich ataxia shows why rare heart disease may be the first test
Europe’s next stroke bet: can Factor XIa inhibition change prevention without raising bleeding risk?
ESC Cardio-Oncology 2026: Cancer therapy is getting smarter. Cardiac protection is still playing catch-up.
Cardio-oncology demand is rising, but training gaps are holding systems back
Personalised cardiology cannot succeed if women’s hearts still follow men’s pathways
AstraZeneca’s Baxfendy opens a new front in uncontrolled hypertension, but monitoring will decide who benefits
Precision cardiology is becoming the new oncology. Policy and reimbursement must catch up
Chronic pain may be a cardiovascular warning sign, not just a symptom
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.